South African Health Products and Regulatory Authority update on Covid-19 Vaccine Janssen resulting in fatal case of Guillain-Barré Syndrome
August 4, 2022
On 31 March 2021, SAHPRA approved the use of the COVID-19 Vaccine Janssen for individuals 18 years of age and older as a single primary